Financhill
Back

Outlook Therapeutics Quote, Financials, Valuation and Earnings

Outlook Therapeutics Price Quote

$1.54
-0.03 (-1.91%)
(Updated: December 12, 2024 at 5:55 PM ET)

Outlook Therapeutics Key Stats

Sell
5
Outlook Therapeutics (OTLK) is a Sell

Day range:
$1.50 - $1.62
52-week range:
$0.87 - $12.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.17
P/B ratio:
0%

Volume:
786.1K
Avg. volume:
3.1M
1-year change:
-81.68%
Market cap:
$37.1M
Revenue:
$0
EPS:
$-10.77

How Much Does Outlook Therapeutics Make?

Data Unavailable

Is Outlook Therapeutics Growing As A Company?

Data Unavailable

Outlook Therapeutics Stock Price Performance

What Is Outlook Therapeutics 52-Week High & Low?

Outlook Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Outlook Therapeutics?

Is Outlook Therapeutics Cash Flow Positive?

  • What Is OTLK Cash Flow From Operations?
    Cash flow from operations (TTM) is -$64.6M
  • What Is Outlook Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $62.9M
  • What Is Outlook Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Outlook Therapeutics Return On Invested Capital

Data Unavailable

Outlook Therapeutics Earnings Date & Stock Price

Outlook Therapeutics Competitors

Outlook Therapeutics Dividend Yield

Outlook Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -43.79%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 24.80
Upside from Last Price: 1479.62%

Major Shareholders

  • How many OTLK shares are owned by institutional investors?
    36.8M OTLK shares are owned by institutional investors
  • How many OTLK shares are owned by insiders?
    10.6M OTLK shares are owned by insiders